Inventory and classify the waste pharmaceuticals by category (expired stock, controlled substances, cytotoxic/chemotherapy agents, non-hazardous, hazardous per RCRA/provincial listing) — the category drives every downstream decision.
Segregate at source into dedicated, labelled containers by category (controlled substances require witnessed destruction under separate regulatory chain-of-custody).
Apply the waste-management hierarchy — return unopened, unexpired stock to the manufacturer/distributor first (reduces the disposal volume), before considering treatment/disposal for the remainder.
Select a licensed hazardous-waste contractor/facility for anything hazardous or controlled, with full manifest tracking (cradle-to-grave documentation under CEPA/provincial hazardous-waste regulations).
Never discharge to sewer or landfill directly — pharmaceuticals are increasingly recognized as emerging contaminants that survive conventional municipal wastewater treatment.
Document and audit the program periodically to confirm compliance and identify opportunities to reduce future waste generation (better inventory/expiry management).
Treatment options:
High-temperature incineration at a licensed hazardous-waste incinerator — the standard method for controlled substances and cytotoxic drugs, destroying the active compound completely.
Chemical deactivation/hydrolysis — for specific compound classes, an acid/base or oxidative treatment breaks down the active pharmaceutical ingredient before landfill disposal of the inert residue.
Encapsulation/inertization (mixing with cement, lime and water to form a solid block) — used where incineration is not locally available, for non-controlled, non-cytotoxic waste.
